Hormones & Reproductive

PT-141 (Bremelanotide)

$44.99

Lot verification pending publication for this compound

Cyclic melanocortin receptor agonist

CAS Number: 189691-06-3
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1025.19 g/mol
Form: Lyophilized
Purity: ≥99% by HPLC-UV

Cold-Packed Protected seasonal packaging

Dispatches ≤48hr From Columbia, SC

Lot Verified COA included with every order

Independently Tested HPLC-UV verified, every single lot

Lot-traceable — matched to a public Certificate of Analysis

Research Use Only — not for human or veterinary use

View Certificate of Analysis

What You Receive

1× Research Vial

PT-141 (Bremelanotide) — nominal content per selected size
Lyophilized
Tamper-evident seal
Lot-numbered label
Lot-matched Certificate of Analysis

Verification

Current Lot & Certificate of Analysis

Lot verification data for this compound hasn’t been published to the COA Library yet.

Browse the COA Library

Specifications

Technical Specifications

CAS Number 189691-06-3

Molecular Formula C₅₀H₆₈N₁₄O₁₀

Molecular Weight 1025.19 g/mol

Physical Form Lyophilized

Purity Specification ≥99% by HPLC-UV

Analytical Method HPLC-UV, 218nm

Research Context

Research Overview

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide melanocortin receptor agonist. CAS 189691-06-3, molecular formula C₅₀H₆₈N₁₄O₁₀, molecular weight 1025.19 g/mol. It is structurally derived from Melanotan II (MT-II) and acts as a non-selective agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R.

Research interest in PT-141 has focused primarily on its central nervous system activity via MC3R and MC4R, which are expressed in hypothalamic and limbic regions associated with autonomic and neuroendocrine regulation. It has been studied in models of melanocortin signaling, reproductive neuroendocrinology, and hypothalamic circuit function. Note: Bremelanotide (Vyleesi) has received FDA approval for a specific clinical indication; this compound is supplied strictly for non-clinical laboratory research purposes.

Supplied as a lyophilized powder. Each lot is independently tested by HPLC-UV with a minimum purity threshold of ≥99.0%. Molecular identity confirmed by LC-MS prior to release. Certificate of Analysis available for every lot number.

For laboratory and in-vitro research use only. Not for human or veterinary use. Not FDA approved.

References

Peer-reviewed literature references for this compound are being compiled and will be published here.

Documentation

Technical Documentation

COA Certificate of Analysis View in COA Library TDS Technical Data Sheet PDF SDS Safety Data Sheet PDF

Fulfillment

Fulfillment & Packaging

Ships From

Columbia, South Carolina

Dispatch Timeframe

Within 48 hours of order confirmation

Cold-Chain Packaging

Insulated, seasonally adjusted packaging protects material in transit

Tamper-Evident Vial

Every vial ships sealed and lot-labeled

Shipping Area

Domestic (U.S.) shipping only

Shipping Cost

Calculated at checkout — see the Shipping Policy for full details

Questions

Frequently Asked Questions

Is this lot independently tested?

Yes. Every lot is tested by an independent third-party laboratory using HPLC-UV before it is released for sale, and results are published in the COA Library.

How do I locate my lot's Certificate of Analysis?

Use the "View Certificate of Analysis" link on this page, or search the COA Library directly by compound name or the lot number printed on your vial label.

What analytical methods are used?

Purity is determined by HPLC-UV. Molecular identity is confirmed by LC-MS prior to release.

How is the material packaged?

Material ships in a tamper-evident, lot-labeled vial inside cold-chain packaging appropriate for the season.

What does "Research Use Only" mean?

This product is sold exclusively for laboratory and in-vitro research applications by qualified researchers. It is not a drug, dietary supplement, or approved for human or veterinary use.